Pfizer’s Hemophilia A Gene Therapy Superior To Prophylaxis In Phase III

A Phase III trial of Pfizer's hemophilia A gene therapy was successful • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Gene Therapies

More from Advanced Therapies